News archive

Read the latest news from the nanomedicine world.

Dear colleagues from the European Community of Nanomedicine, we are glad to share with you a 2-week deadline extension for the survey of WG on Nanomedicines of the International Pharmaceutical Regulators Programme  (IPRP) about the needs for research & regulation of liposome products. You are more than welcome to answer this important international consultation on Nanomedicine before September 14, following the instructions below.


In 2016, a survey was conducted among the International Pharmaceutical Regulators Forum (IPRF) Nanomedicine Working Group  (NWG) members to map and exchange regulatory requirements for medicines that contain liposomal products (Link for survey results).

In Jan 2018, the IPRF and the International Generic Drug Regulators Programme (IGDRP) were consolidated to establish the International Pharmaceutical Regulators Programme (IPRP). The membership of the IPRP NWG has since expanded and currently there are 12 members and observers represented in the group (Link for IPRP NWG Members and Observers).  The focus of IPRP NWG include non-confidential information sharing, regulatory harmonization or convergence focused on nanomedicines/nanomaterials in drug products, borderline and combination products, and follow-on nanomedicines.

How to answer the survey

  1. Please download the consultation by clicking on this link
  2. Please send back your survey responses by Sept. 14th 2020 at the latest at:

Thank you in advance for your cooperation.

With kind regards,

The ETPN Secretariat.